• $21.9M
    Market Cap
  • -67.75%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
0
-100.00%
1.9M
-90.55%
19.9M
+21.60%
16.4M
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
-100.00%
1.9M
-90.55%
19.9M
+21.60%
16.4M
N/A
Sales and Marketing Expense
12.4M
-13.27%
14.3M
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-44.8M
-20.56%
-56.4M
+35.09%
-41.8M
-22.29%
-53.8M
+52.43%
Depreciation and Amortization Expense
1.6M
-9.92%
1.8M
+2.83%
1.8M
+59.78%
1.1M
+411.11%
Total Operating Expenses
60.7M
-19.61%
75.5M
+24.87%
60.4M
-16.58%
72.5M
+44.66%
Operating Profit
-60.7M
-17.55%
-73.6M
+81.70%
-40.5M
-27.75%
-56.1M
+11.92%
Interest Income
3.1M
-53.42%
6.7M
-10.02%
7.4M
N/A
N/A
N/A
Interest Expense
-5.3M
+59.29%
-3.3M
+5.48%
-3.1M
N/A
N/A
N/A
Interest Income and Expense and Net
-2.2M
-164.43%
3.4M
-21.39%
4.3M
N/A
0
N/A
Total Nonoperating Income and Expense
-145,000
-104.71%
3.1M
-1.79%
3.1M
+39.58%
2.2M
+2,059.62%
Income before Taxes
-60.7M
-17.55%
-73.6M
+81.70%
-40.5M
-24.73%
-53.8M
-73.35%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-60.8M
-13.75%
-70.5M
+88.70%
-37.4M
-30.56%
-53.8M
+7.66%
Net Income from Continuing Operations Applicable to Common
-60.8M
-13.75%
-70.5M
+88.70%
-37.4M
-30.56%
-53.8M
-73.35%
Basic EPS and Net Income
-1.32
-19.02%
-1.63
+55.24%
-1.05
-43.55%
-1.86
-83.00%
Diluted EPS and Net Income
-1.33
-18.40%
-1.63
+55.24%
-1.05
-43.55%
-1.86
-83.00%
Basic Weighted Average Shares
46.0M
+6.20%
43.3M
+21.56%
35.6M
+23.50%
28.9M
+56.40%
Diluted Weighted Average Shares
46.8M
+6.73%
43.9M
+23.04%
35.6M
+23.50%
28.9M
+56.40%
Balance Sheet
Cash and Cash Equivalents
57.0M
-48.60%
111.0M
-17.38%
134.3M
+3.89%
129.3M
-17.91%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
57.0M
-48.60%
111.0M
-17.38%
134.3M
+3.89%
129.3M
-17.91%
Total Current Assets
58.6M
-48.18%
113.1M
-18.29%
138.4M
-1.31%
140.2M
-12.96%
Accumulated Depreciation
6.6M
+32.78%
5.0M
+57.22%
3.2M
+125.46%
1.4M
+259.59%
Property and Plant and Equipment and Net
4.7M
-25.85%
6.3M
-20.56%
8.0M
-11.46%
9.0M
+208.55%
Total Long-Term Assets
5,000
-98.44%
320,000
-46.13%
594,000
-56.96%
1.4M
+112.63%
Total Assets
69.4M
-45.33%
126.9M
-27.40%
174.8M
+9.10%
160.2M
-10.60%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
28.2M
N/A
0
-100.00%
6.7M
N/A
N/A
N/A
Total Current Liabilities
36.1M
+138.13%
15.2M
-21.66%
19.4M
-19.22%
24.0M
+102.03%
Total Long-Term Debt
0
-100.00%
26.1M
-20.09%
32.7M
-18.36%
40.0M
N/A
Total Long-Term Liabilities
8.4M
-77.99%
38.4M
N/A
0
-100.00%
191,000
N/A
Total Liabilities
44.6M
-16.71%
53.5M
-15.63%
63.5M
+67.40%
37.9M
+43.25%
Retained Earnings
-475.4M
+14.67%
-414.6M
+20.49%
-344.1M
+12.18%
-306.7M
+21.28%
Total Stockholders Equity
24.8M
-66.20%
73.4M
-34.10%
111.4M
-8.96%
122.3M
-19.93%
Total Shares Outstanding
48.6M
+8.41%
44.8M
+14.63%
39.1M
+24.41%
31.4M
+15.09%
Cash Flow
Cash from Operating Activities
-60.3M
+7.30%
-56.2M
+72.29%
-32.6M
-19.67%
-40.6M
-5.32%
Capital Expenditures
0
-100.00%
254,000
-66.97%
769,000
-78.70%
3.6M
+625.10%
Cash from Investing Activities
0
+100.00%
-254,000
-66.97%
-769,000
-78.70%
-3.6M
+625.10%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
6.0M
-53.91%
13.1M
-77.61%
58.4M
+267.34%
15.9M
-85.46%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
-3,904.19%
+1,822.36%
-203.09%
-40.58%
-341.78%
N/A
Return on Assets
-61.96%
+32.58%
-46.74%
+109.54%
-22.30%
-29.64%
-31.70%
N/A
Return on Equity
-123.88%
+62.30%
-76.33%
+138.69%
-31.98%
-18.25%
-39.12%
N/A
Revenue Growth
-100.00%
+10.44%
-90.55%
-519.28%
21.60%
N/A
N/A
N/A
Current Ratio
1.62
-78.24%
7.45
+4.31%
7.14
+22.18%
5.84
N/A
Cash Ratio
1.58
-78.42%
7.31
+5.47%
6.93
+28.61%
5.39
N/A
Debt-to-Equity Ratio
1.14
+220.11%
0.36
+0.71%
0.35
N/A
N/A
N/A
Debt-to-Assets Ratio
0.41
+97.91%
0.21
-8.58%
0.22
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow